Citius Oncology Inc. (CTOR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Citius Oncology Inc.

    NASDAQ: CTOR · Real-Time Price · USD
    1.89
    0.01 (0.53%)
    At close: Oct 03, 2025, 3:59 PM
    1.86
    -1.59%
    After-hours: Oct 03, 2025, 06:05 PM EDT

    Citius Oncology Ratios and Metrics

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Dec 31, 2021
    PE Ratio
    		 -4.7 -80.55 -189.69 -92K
    PEG Ratio
    		 -0.08 -0.54 -0.03 n/a
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 2.16 40.05 28.41 n/a
    P/FCF Ratio
    		 -20.41 -1.7K -21.48K n/a
    P/OCF Ratio
    		 787.14 -1.7K -21.48K n/a
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.08 n/a n/a n/a
    Quick Ratio
    		 0.08 0.37 0.46 n/a
    Current Ratio
    		 0.34 0.37 0.46 n/a
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.46 -0.5 -0.15 n/a
    Return on Assets
    		 -0.25 -0.27 -0.13 n/a
    Return on Invested Capital
    		 -0.41 -0.48 -0.15 n/a
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist